FMC (FMC) concentration risks

The company's disclosed concentration profile combines a product-level tilt toward a flagship active ingredient and a geographic supplier dependency, both of which are structural features of the agricultural chemistry business. The most prominent exposure is the product concentration around the Rynaxypyr® active (chlorantraniliprole), which the filing describes as the world's leading insect control technology with annual revenues of approximately $0.8 billion in 2025 — a medium share of the overall portfolio by disclosed size and structural in character. A second proprietary active, Cyazypyr® (cyantraniliprole), supported a product portfolio generating approximately $0.4 billion in revenues in 2025 — a small share by disclosed size, also structural. Together these two actives represent the core of the crop protection pipeline, meaning research productivity, patent duration, regulatory standing, and generic entry timing for these compounds are the primary product-level risk variables. The supply chain introduces a medium-share dependency: critical intermediates and finished products are sourced from suppliers largely outside the U.S. and principally in China and India. This is structural in the sense that the agrochemical supply chain globally relies on Asian intermediate chemistry, but it also carries a dependency character — trade policy changes, export controls, or regional disruptions affecting Chinese or Indian chemical suppliers could impair production economics or availability. The product and supplier exposures compound each other, since cost increases in sourced intermediates would most directly affect the margins on the flagship actives that drive the bulk of the revenue base.

For the engine’s reasoning on FMC’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.